US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

104.42

+2.422.37%

Volume:22.59K

Turnover:2.37M

Market Cap:130.52M

PE:- -

High:105.51

Open:103.98

Low:103.98

Close:102.00

52wk High:110.05

52wk Low:68.05

Shares:1.25M

Float Shares:1.25M

Volume Ratio:4.06

T/O Rate:1.81%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

Aurinia settles patent litigation with Teva

Marvel Biosciences Extends Private Placement Access to Quebec Investors

Femasys announces FDA approval of FemBloc modular premarket approval application

Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback

Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G

Amylyx Phase 3 data support FDA approval, says Citi

Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning

Coherus Oncology issuing special dividend of biosimilar contingent value rights

TYK Medicines Clarifies Board Structure and Committee Roles

Sandoz expands biosimilar pipeline with major Henlius collaboration

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure

U.S. Stock Futures Flat as Traders Await Key Inflation Report

Australia’s biggest bank reports major drop in home loan applications‘There are clearly pockets of customer stress, given higher living costs and higher interest rates’.2 min read

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Press Release: Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BBP/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":104.415,"timestamp":1789665329300,"preClose":101.9998,"halted":0,"volume":22585,"delay":0,"changeRate":0.023678477800936994,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Trading","change":2.4152,"latestTime":"09-17 13:23:54 EDT","open":103.975,"high":105.505,"low":103.975,"amount":2370968.1957900003,"amplitude":0.015,"askPrice":104.41,"askSize":100,"bidPrice":103.2,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.9998,"sharesOutstanding":600004,"nav":101.285,"aum":121542550.39,"bidAskSpread":0.002402,"preHourTrading":{"tag":"盘前","latestPrice":101.9998,"preClose":101.9998,"latestTime":"07:00 EDT","volume":1,"amount":101.9998,"timestamp":1789642858616,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":101.73,"preClose":101.9998,"latestTime":"19:30 EDT","volume":32,"amount":3268.2282,"timestamp":1789601403689,"change":-0.2698,"changeRate":-0.002645,"amplitude":0},"volumeRatio":4.060152,"impliedVol":0.2248,"impliedVolPercentile":0.4343},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.060152,"shares":1250004,"dividePrice":0,"high":105.505,"amplitude":0.015,"preClose":101.9998,"low":103.975,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":104.415,"eps":0,"divideRate":0,"volume":22585,"delay":0,"ttmEps":0,"open":103.975,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":103.4736,"twentyDayClose":109.9037,"sixtyDayClose":92.7358},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660473649","title":"Press Release: Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473649?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:30","pubTimestamp":1787171400,"startTime":"0","endTime":"0","summary":"-- Gross Margin of 54% was broadly level with the same period last year.-- Adjusted EBITDA2 was $46.9 million compared to $53.7 million in the same. -- Cash-balance at the end of the period was $142.8 million compared to. -----------------------------------------  --------  --------  ---------Q2 2026 business highlights-- Alvotech resubmitted US Biologics License Applications for AVT05,proposed biosimilar to Simponi and Simponi Aria and AVT06, proposed. biosimilar to Eylea, following the comprehensive responses to the US. -- Alvotech's partner, Dr. Reddy's Laboratories, resubmitted the US. Biologics License Application for AVT03, proposed biosimilar to. -- FDA confirmed review completion goal dates in alignment with the standard. 6-month process, with decisions anticipated in the fourth quarter of. -- FDA closed its inspection of the company's manufacturing facility in. Reykjavik, conducted in April-May 2026, and confirmed a VAI. -- Alvotech closed an underwritten public offering and p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO","R","BK4022","BK4139","BBP","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660532473","title":"Aurinia settles patent litigation with Teva","url":"https://stock-news.laohu8.com/highlight/detail?id=2660532473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660532473?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:11","pubTimestamp":1787170262,"startTime":"0","endTime":"0","summary":"Aurinia Pharmaceuticals (AUPH) announced that it and its subsidiary, Aurinia Pharma U.S., Inc., have entered into a settlement agreement with Teva ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aurinia-settles-patent-litigation-with-teva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aurinia-settles-patent-litigation-with-teva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXTI","MEDX","BK4139","AUPH","BBP","RND","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747836","title":"Marvel Biosciences Extends Private Placement Access to Quebec Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747836?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:08","pubTimestamp":1787166508,"startTime":"0","endTime":"0","summary":"Marvel Biosciences Corp ( ($TSE:MRVL) ) has provided an announcement. Marvel Biosciences Corp. is a Calgary-based pre-clinical biotechnology compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-extends-private-placement-access-to-quebec-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-extends-private-placement-access-to-quebec-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","SYNB","BK4211","DARP","XT","FHLC","JDOC","FWD","BBP","BK4588","IEIH","IBB","BK4585","AGNG","LNGR","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660252964","title":"Femasys announces FDA approval of FemBloc modular premarket approval application","url":"https://stock-news.laohu8.com/highlight/detail?id=2660252964","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660252964?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:16","pubTimestamp":1787145413,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that the FDA has approved the company’s modular premarket approval application pathway for FemBloc, its investigational no...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","MRNX","NVIB","IEIH","BK4588","BK4584","RSPH","LABU","PINK","MRNY","TBXU","IDNA","BBP","MEDI","LFSC","FRTY","IBB","PSCH","BK4585","SYNB","IYH","BK4539","TECB","FEMY","GNMX","GDOC","XLVX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184678054","title":"Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback","url":"https://stock-news.laohu8.com/highlight/detail?id=1184678054","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184678054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:15","pubTimestamp":1787127336,"startTime":"0","endTime":"0","summary":"Andy Acker, Portfolio Manager for healthcare and biotech strategies at Janus Henderson Investors, notes that despite interest rates remaining higher than markets anticipated at the start of the year,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","IYG","BK4588","BIB","IBBJ","MRNY","BBP","BBC","IBB","IJT","BK4585","IAI","BIS","QSML","SPCK","FBT","IWO","BK4582","GTPE","PBE","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660041502","title":"Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G","url":"https://stock-news.laohu8.com/highlight/detail?id=2660041502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660041502?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:42","pubTimestamp":1787103774,"startTime":"0","endTime":"0","summary":"Percheron Therapeutics ( ($AU:PER) ) just unveiled an announcement. Percheron Therapeutics Limited, an ASX-listed biotechnology company, has publis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-files-asx-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-files-asx-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IEIH","FHLC","BK4585","BK4539","AGNG","DARP","JDOC","BBP","IBB","LENZ","RSPH","SYNB","FWD","LNGR","BK4588","BK4139","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660595493","title":"Amylyx Phase 3 data support FDA approval, says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660595493","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660595493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:05","pubTimestamp":1787061936,"startTime":"0","endTime":"0","summary":"Citi says Amylyx’s (AMLX) avexitide showed a “highly differentiated” profile in the Phase 3 LUCIDITY study, a 78 participant, placebo-controlled tr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","TECB","FRTY","IEIH","GNMX","SYNB","GDOC","BK4588","IDNA","TBXU","RSPH","BBP","MRNX","AMLX","PINK","BK4007","IBB","PSCH","MRNY","MEDI","NVIB","IYH","BK4585","BMED","XLVX","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468019","title":"Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468019?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:33","pubTimestamp":1787041986,"startTime":"0","endTime":"0","summary":"An announcement from Anatara Lifesciences Ltd ( ($AU:ANR) ) is now available. Anatara Lifesciences Ltd is a biotechnology company focused on develo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SYNB","BK4588","AGNG","LNGR","BBP","RSPH","FHLC","FWD","JDOC","IBB","XT","IEIH","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660475437","title":"Coherus Oncology issuing special dividend of biosimilar contingent value rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2660475437","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660475437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:40","pubTimestamp":1787002809,"startTime":"0","endTime":"0","summary":"Coherus Oncology (CHRS) announced a special dividend of contingent value rights which will be distributed on a pro rata basis to stockholders of re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coherus-oncology-issuing-special-dividend-of-biosimilar-contingent-value-rights-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coherus-oncology-issuing-special-dividend-of-biosimilar-contingent-value-rights-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACTV","CHRS","ACKY","BK4585","VIG","BBP","BK4535","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448056","title":"TYK Medicines Clarifies Board Structure and Committee Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448056?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:38","pubTimestamp":1786970320,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. Class H ( ($HK:2410) ) just unveiled an update. TYK Medicines, Inc., a Hong Kong-listed pharmaceutical and biotechnology compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tyk-medicines-clarifies-board-structure-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tyk-medicines-clarifies-board-structure-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","FWD","XT","JDOC","BK4585","AGNG","RSPH","LNGR","FHLC","IBB","MDCO","BBP","DARP","IEIH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105197","title":"Sandoz expands biosimilar pipeline with major Henlius collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105197","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660105197?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:32","pubTimestamp":1786926779,"startTime":"0","endTime":"0","summary":"Sandoz Group Ltd ( ($CH:SDZ) ) has issued an announcement. Sandoz has signed a major development, manufacturing and commercialization deal with Sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sandoz-expands-biosimilar-pipeline-with-major-henlius-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sandoz-expands-biosimilar-pipeline-with-major-henlius-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBP","161027","BK4588","XLVI","06881","WRND","GSKH","BK0188","601881","BK4585","PBE","BK0276","BK1147","LFSC","BIOY","BK1564","GDOC","APXH","IBB","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659926188","title":"Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659926188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659926188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:37","pubTimestamp":1786567029,"startTime":"0","endTime":"0","summary":"The latest update is out from Outlook Therapeutics ( ($OTLK) ). On July 24, 2026, Outlook Therapeutics announced U.S. FDA approval of LYTENAVA (bev...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","XLVX","BMED","PSCH","BK4539","LFSC","BK4585","MRNX","IEIH","LABU","BK4007","BK4139","FRTY","NVIB","IYH","RSPH","BBP","GNMX","BK4588","IDNA","MRNY","PINK","SYNB","IBB","MEDI","LENZ","TECB","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990095","title":"Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990095","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990095?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- AEON held a successful Biosimilar Biological Product Development.  Type 2a meeting with the U.S. Food and Drug Administration.  during the first quarter of 2026. During the meeting, the. strategy under the 351 biosimilar pathway and provided feedback. ABP-450. Collectively, the FDA's feedback provided AEON with. well-defined direction and a framework for the remaining. analytical components of its biosimilar development program. The. associated with characterizing the 900 kDa botulinum neurotoxin. complex due to its large size and exceptional potency, while. analytical assessment plan. The Company looks forward to feedback. from its planned BPD Type 2b interaction with the FDA in the. second half of 2026, which is expected to help inform the next. phase of development for ABP-450, including clinical pharmacology. -- Strengthened Balance Sheet through a $15.3 Million Financing with","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4232","BK4588","BBP","BK4022","R","AEON","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463773","title":"Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142463773?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:10","pubTimestamp":1786543834,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) issued a statement on August 12, revealing that its stock price has experienced an unusual surge, with cumulative closing price gains exceeding...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GDOC","BK4588","BBP","WRND","BK0102","LFSC","GSKH","APXH","600721","XLVI","BK0216","IBB","SBIO","BIOY","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949156","title":"U.S. Stock Futures Flat as Traders Await Key Inflation Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949156?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:14","pubTimestamp":1786486471,"startTime":"0","endTime":"0","summary":"U.S. stock futures were steady on Tuesday evening as traders waited for a key inflation report that could guide the next move on interest rates. Fu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/u-s-stock-futures-flat-as-traders-await-key-inflation-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/u-s-stock-futures-flat-as-traders-await-key-inflation-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IJK","BBP","IUS","DECU","REGL","TSLP","HIDV","MAPP","CAOS","CGDV","RHTX","FXD","ANEW","DFUV","MDLV","FLV","CDC","MODL","CLIX","BSR","VTV","PSC","KOMP","VAW","RULE","BKDV","EES","CGUI","ARP","SAMT","SDOG","EQRR","FXL","CGUS","UCC","IMCG","DIVZ","LGH","LCG","FT","TEQI","ADPV","VOTE","FXR","MATR","ILCV","AVSD","BAMA","PRVS","PEVC","RMIF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928457","title":"Australia’s biggest bank reports major drop in home loan applications‘There are clearly pockets of customer stress, given higher living costs and higher interest rates’.2 min read","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928457","media":"7NEWS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658928457?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:00","pubTimestamp":1786464000,"startTime":"0","endTime":"0","summary":"Be the first to know: Add 7NEWS as your preferred news source on GoogleCBA’s annual report highlights a focus on AI, with 80 per cent of its staff now using the technology each week. The bank has opened an office in Silicon Valley to partner with AI developers as its seeks to deliver better customer service at greater speed. “We think we’re going to get a lot more done, given the velocity benefits,” said Docherty.However, CBA noted AI was a double-edged sword and being weaponised by scammers, with the bank now spending a billion dollars a year to protect customers from increasingly sophisticated fraud. It’s sending 40,000 fraud alerts to customers each day.CommBank is the nation’s biggest financial institution, with one in three Australians naming it as their primary bank. It now boasts 18.6-million customers, with the largest branch network in the land. The bank says its popular app is now recording more than 14-million log-ins each day.Driver’s terrifying near-miss with iconic touris","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"7news_stock","url":"https://7news.com.au/news/commonwealth-bank-warns-economic-growth-is-slowing-reports-major-drop-in-home-loan-applications-c-22712205","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://7news.com.au/news/commonwealth-bank-warns-economic-growth-is-slowing-reports-major-drop-in-home-loan-applications-c-22712205","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"7news_stock","symbols":["TSLG","XKO.AU","DACE.AU","CLIX","QOWZ","TSL","VAS.AU","QRE.AU","FXL","TSLI","E200.AU","OZR.AU","IJK","TSLY","XAO.AU","AVSD","OZF.AU","PEVC","FXR","LRCY","UCC","IMLC.AU","PEX","TSDD","BEAR.AU","VAW","BBP","TSLO","BBOZ.AU","ELOL","IISV.AU","CAOS","TSLQ","EIGA.AU","IOZ.AU","TSII","ANEW","TSLS","CRSH","TSLR","TSYY","TSLP","DFND","RWVG","CGDV","ZYAU.AU","KOMP","RJZ","XJO.AU","DFUV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","PBE","BK4588","BBP","BK0216","BK4585","IBB","WRND","APXH","SBIO","600721","XLVI","BIOY","GDOC","GSKH","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118729610","title":"AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1118729610","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118729610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:12","pubTimestamp":1786428745,"startTime":"0","endTime":"0","summary":"A research report from Orient Securities Company Limited highlights that as global regulatory shifts accelerate, the large-scale application of AI in pharmaceuticals is rapidly advancing. It has...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","03958","BK1147","BK4588","IBB","LFSC","BK0012","VTHR","SBIO","GDOC","AIPO","BK1564","WRND","BK0028","BK0188","QTOC","600958","CHAT","BK4585","ARTY","PBE","BBP","AGIX","APXH","GSKH","XLVI","BIOY","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993909","title":"Press Release: Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993909","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993909?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:01","pubTimestamp":1786366860,"startTime":"0","endTime":"0","summary":"Seasoned biotechnology founder, public company CFO and corporate strategist brings more than 25 years of leadership in oncology, capital markets, M&A and corporate governanceAppointment further streng","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","SYNB","BK4588","BBP","IBB","LENZ","XBI","BK4233","BK4007","BK4539","BK4581","ERNA","BK4205","BK4139","BK4585","RFL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":179,"code":"91000000","status":"200"}]}}